Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Share-based Compensation (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Share-based Compensation for 15 consecutive years, with $72443.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Share-based Compensation fell 47.93% year-over-year to $72443.0, compared with a TTM value of $415234.0 through Mar 2025, down 65.95%, and an annual FY2025 reading of $415234.0, down 65.95% over the prior year.
  • Share-based Compensation was $72443.0 for Q1 2025 at Aethlon Medical, down from $89970.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $572955.0 in Q4 2023 and bottomed at $72443.0 in Q1 2025.
  • Average Share-based Compensation over 5 years is $211019.9, with a median of $201062.0 recorded in 2021.
  • The sharpest move saw Share-based Compensation surged 118.17% in 2023, then crashed 84.3% in 2024.
  • Year by year, Share-based Compensation stood at $201019.0 in 2021, then surged by 30.64% to $262613.0 in 2022, then soared by 118.17% to $572955.0 in 2023, then plummeted by 84.3% to $89970.0 in 2024, then decreased by 19.48% to $72443.0 in 2025.
  • Business Quant data shows Share-based Compensation for AEMD at $72443.0 in Q1 2025, $89970.0 in Q4 2024, and $113493.0 in Q3 2024.